Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Versari

Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.

Hematological Oncology

English

Disease Activity Assessment in Large Vessel Vasculitis

Reumatismo

Rheumatology

2011

English

Related publications

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Journal of Clinical Oncology

English

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi

Hematological Oncology

English

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Combined Therapy in Advanced Stages (III and IV) of Follicular Lymphoma Increases the Possibility of Cure: Results of a Large Controlled Clinical Trial

European Journal of Haematology

Medicine

Hematology

2002

English

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Haematologica

Hematology

2018

English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology

English

Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Versari

Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.

Disease Activity Assessment in Large Vessel Vasculitis

Related publications

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Pet-Driven Radiotherapy in Patients With Low Risk Diffuse Large B-Cell Lymphoma (Dlbcl): The Dlcl10 Multicenter Phase 2 Trial by Fondazione Italiana Linfomi (Fil)

Dose Dense Abvd (Dd-Abvd) as First Line Therapy in Early-Stage Unfavorable Hodgkin Lymphoma (Hd): Results of a Phase Ii, Prospective Study by Fondazione Italiana Linfomi

The Elderly Project by the Fondazione Italiana Linfomi: A Prospective Comprehensive Geriatric Assessment (Cga) of 1353 Elderly Patients With Diffuse Large B-Cell Lymphoma

Combined Therapy in Advanced Stages (III and IV) of Follicular Lymphoma Increases the Possibility of Cure: Results of a Large Controlled Clinical Trial

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma